Degarelix
Degarelix
Degarelix (pronounced: deh-gah-REH-lix) is a hormone therapy drug used in the treatment of prostate cancer. It is classified as a gonadotropin-releasing hormone (GnRH) antagonist.
Etymology
The name 'Degarelix' is derived from its chemical structure. The prefix 'de-' is Latin for 'from' or 'of', while 'garelix' is a unique identifier for the compound. The exact etymology is not known.
Usage
Degarelix is used to treat advanced prostate cancer. It works by reducing the amount of testosterone in the body, which prostate cancer cells need to grow. By blocking the production of testosterone, degarelix can slow the growth of prostate cancer cells.
Related Terms
- Gonadotropin-releasing hormone (GnRH): A hormone that controls the production of testosterone in the body.
- Prostate cancer: A type of cancer that occurs in the prostate, a small gland that produces the seminal fluid that nourishes and transports sperm.
- Testosterone: A hormone that plays a key role in the development of male reproductive tissues such as the testes and prostate, as well as promoting secondary sexual characteristics such as increased muscle and bone mass, and the growth of body hair.
Side Effects
Common side effects of degarelix include hot flashes, injection site reactions, weight gain, and increased levels of liver enzymes. More serious side effects can include allergic reactions, liver damage, and heart disease.
See Also
External links
- Medical encyclopedia article on Degarelix
- Wikipedia's article - Degarelix
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski